Managing chronic disease in Ireland: hospital admission rates and clinical outcomes in a large ulcerative colitis population

Ir J Med Sci. 2012 Mar;181(1):65-71. doi: 10.1007/s11845-011-0760-y. Epub 2011 Sep 24.

Abstract

Background: Health care planning demands a detailed knowledge of the course of chronic diseases in the Irish population. This study describes hospital admission rates, medication use and outcomes in a large cohort of patients with ulcerative colitis attending a tertiary referral centre in Ireland.

Method: Four hundred and twenty-four patients who attended during the 18-year period from January 1991 to January 2009 were identified. Baseline demographics, hospital admission, medications required, extent of colitis and date of colectomy were recorded.

Results: More than half (55.4%) of the patients were managed exclusively in an outpatient setting throughout diagnosis and follow-up. Systemic corticosteroids, thiopurines and infliximab were required by 70, 29.5 and 5% of the patients, respectively. Overall 5-year colectomy rate due to failure of medical therapy was 15.8%. Independent predictors of colectomy were hospital admission at first presentation (odds ratio 3.6, p < 0.0001) and pancolitis at diagnosis (odds ratio 2.3, p < 0.01).

Conclusions: The majority of patients with colitis have an uncomplicated disease course and do not require thiopurines, biologic agents or hospital admission. Principal management at a primary care level may be appropriate in many cases. Colectomy rates at a specialist centre in Ireland compare favourably with international figures.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Anti-Inflammatory Agents / therapeutic use
  • Antibodies, Monoclonal / therapeutic use
  • Azathioprine / therapeutic use
  • Child
  • Child, Preschool
  • Colectomy / statistics & numerical data*
  • Colitis, Ulcerative / diagnosis
  • Colitis, Ulcerative / drug therapy*
  • Colitis, Ulcerative / surgery
  • Female
  • Hospitalization / statistics & numerical data*
  • Humans
  • Hydrocortisone / therapeutic use
  • Immunosuppressive Agents / therapeutic use
  • Infant
  • Infliximab
  • Ireland
  • Male
  • Mercaptopurine / therapeutic use
  • Middle Aged
  • Prednisolone / therapeutic use
  • Young Adult

Substances

  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal
  • Immunosuppressive Agents
  • Prednisolone
  • Infliximab
  • Mercaptopurine
  • Azathioprine
  • Hydrocortisone